Europe reviews Valneva's chikungunya vaccine after reports of serious side effects
(Reuters) -The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after reports of serious side effects in older adults.
The European Medicines Agency's (EMA) safety committee has temporarily suspended the use of the vaccine, branded as Ixchiq, in adults aged 65 years and older.
The company said it will continue to monitor the reported events and cooperate with health authorities, while actively exploring a potential update to the vaccine's indication.
Ixchiq -- the first preventive shot against chikungunya virus to be authorized in the Europe as well as the U.S. -- contains a weakened strain of the virus that triggers the immune system to make antibodies.
The vaccine carries the risk of causing severe chikungunya-like adverse reactions, the EMA said in a statement.
Chikungunya is a mosquito-borne disease caused by the chikungunya virus. The most common symptoms of the infection are fever and joint pain.
About 17 serious adverse events, including two deaths, have been reported so far globally in people aged between 62 and 89 years who had received the vaccine, the agency said.
Two men aged 84 years and 77 years who had received the vaccine died in the French overseas territory of La Reunion, where a recent chikungunya outbreak has been reported.
The exact cause of the adverse events and their relationship with the vaccine have not yet been determined, the agency said, adding that the affected individuals also had other health conditions.
The French government suspended the use of the vaccine in persons aged 65 years and older last month pending investigation.
Advisers to the U.S. Centers for Disease Control and Prevention had recommended the vaccine last month for adults traveling to a country or territory where there is a chikungunya outbreak. The recommendation is yet to be signed off by the CDC.
(Reporting by Mariam Sunny in Bengaluru; Editing by Tasim Zahid and Shinjini Ganguli)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Harvard seeks end to US funding cuts, says national security, public health research in peril
By Tom Hals WILMINGTON, Delaware (Reuters) -Harvard University asked a federal judge on Monday to issue a summary judgment ruling to unfreeze $2.5 billion in funding blocked by President Donald Trump's administration, which Harvard said was illegal. Harvard's filing in the U.S. District Court in Boston said that it had received 957 orders since April 14 to freeze funding for research pertaining to national security threats, cancer and infectious diseases and more since the country's oldest and wealthiest school rejected a White House list of demands. Trump has said he is trying to force change at Harvard - and other top-level universities across the U.S. - because in his view they have been captured by leftist "woke" thought and become bastions of antisemitism. The Trump administration did not immediately respond to a request for comment. U.S. District Judge Allison Burroughs has set arguments for July 21 on Harvard's motion for summary judgment, which is a request for a judge to decide a dispute without a trial to determine material facts. Harvard sued the Trump administration in April, alleging the funding freeze violated the school's right to free speech and was arbitrary and capricious. In Monday's court filing, Harvard detailed the terminated grants, including $88 million for research into pediatric HIV, $12 million for increasing Defense Department awareness of emerging biological threats and $8 million to better understand dark energy. The school said ending the funding would destroy ongoing research into cancer treatments, infectious disease and Parkinson's. The Trump administration has opened numerous investigations into Harvard. Some are looking at threats against Jewish students and faculty after pro-Palestinian protests broke out following the Oct. 7, 2023 Hamas attack on Israel and subsequent Israeli military actions in Gaza. Other investigations are probing whether Harvard discriminates based on sex and gender, along with the school's ties to foreign governments and international students. The Trump administration revoked Harvard's ability to enroll international students last month, which a judge temporarily blocked after Harvard sued in a separate case. Harvard and other universities say Trump's attacks are threats to freedom of speech and freedom of academics, as well as threats to the schools' very existence.
Yahoo
3 hours ago
- Yahoo
Ukrainian strikes cut power to Russian-held areas, officials say
(Reuters) -Ukrainian shelling and drone attacks triggered power cuts over swathes of Russian-controlled territory in Zaporizhzhia and Kherson regions in the south of Ukraine, Russia-installed officials said early on Tuesday. Officials said there was no effect on operations at the Zaporizhzhia nuclear power station - Europe's largest nuclear facility which was seized by Russia in the weeks after Moscow's February 2022 invasion of Ukraine. Russian officials running the plant said radiation levels were normal at the facility, which operates in shutdown mode and produces no power at the moment. Russia-installed governors in the two regions said the Ukrainian attacks prompted authorities to introduce emergency measures and switch key sites to reserve power sources. Power was knocked out to all parts of Zaporizhzhia under Russian control, Russia-installed Governor Yevgeny Belitsky wrote on Telegram. "As a result of shelling by the Ukrainian Armed Forces, high-voltage equipment was damaged in the northwestern part of the Zaporizhzhia region," Belitsky wrote. "There is no electricity throughout the region. The Energy Ministry of Zaporizhzhia region has been instructed to develop reserve sources of power. Health care sites have been transferred to reserve power sources." In adjacent Kherson region, farther west, Russia-appointed Governor Vladimir Saldo said debris from fallen drones had damaged two substations, knocking out power to more than 100,000 residents of 150 towns and villages in Russian-held areas. Emergency crews working to restore power quickly, he said. For many long months in the winter, it was Ukrainian towns and villages that endured repeated electricity cuts as Russian attacks focused strikes on generating capacity. Each side has repeatedly accused the other of launching attacks on the Zaporizhzhia nuclear plant and running the risk of a nuclear accident. The U.N. nuclear watchdog, the International Atomic Energy Agency, said last week in response to a Ukrainian complaint that it saw no sign that Russia was preparing to restart the Zaporizhzhia plant and connect it to the Russian grid. The IAEA has stationed monitors permanently at Zaporizhzhia and Ukraine's other nuclear power stations.
Yahoo
4 hours ago
- Yahoo
US FDA launches AI tool to reduce time taken for scientific reviews
(Reuters) -The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews. "Today's rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers," said FDA Commissioner Marty Makary. The agency said it is already using Elsa to expedite clinical protocol reviews, shorten the time needed for scientific evaluations, and pinpoint high-priority inspection targets. Once the FDA receives an application for a potential drug approval, it has six to 10 months to make a decision. Elsa assists with reading, writing, and summarizing tasks. It can summarize adverse events to support safety profile assessments of drugs and rapidly compare packaging inserts. "Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff," the FDA said. In May, the regulator said it would fully integrate AI by June 30, following an experimental run.
